Difference between revisions of "Paliperidone ER-Lurasidone"
From Psychiatrienet
(Created page with "<big><span style="color:#ff0000"> * This switch is intended for paliperidone long acting (Xeplion®, 30 days) </span></big> {{Drugswitch | from = Paliperidone LA | to = Lura...") |
|||
| Line 5: | Line 5: | ||
| to = Lurasidone | | to = Lurasidone | ||
| stop = {{Lastinjection}} | | stop = {{Lastinjection}} | ||
| − | | start = {{ | + | | start = {{StartOral afterDepot} |
| info = | | info = | ||
{{RefSwitchToLurasidone}} | {{RefSwitchToLurasidone}} | ||
| − | + | * the T<sub>1/2</sub> of a monthly paliperidon depot is approximately '''25-49 days'''.<ref> KNMP Kennisbank, informatorium medicamentorum: Olanzapine</ref> | |
| + | |||
}} | }} | ||
Revision as of 14:09, 20 February 2025
* This switch is intended for paliperidone long acting (Xeplion®, 30 days)
{{Drugswitch | from = Paliperidone LA | to = Lurasidone | stop =
- Day 1: Last depot injection
| start = {{StartOral afterDepot} | info =
- More information on switching to lurasidon: see reference. [1]
- the T1/2 of a monthly paliperidon depot is approximately 25-49 days.[2]
}}
- ↑ McEvoy JP et al. Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.J Clin Psychiatry. 2013 Feb;74(2):170-9.
- ↑ KNMP Kennisbank, informatorium medicamentorum: Olanzapine
